Site icon pharmaceutical daily

CURE Media Group Announces the 2020 MPN Heroes® Winners

Annual awards program recognizes extraordinary patients, health care professionals and caregivers for their outstanding efforts in bringing understanding, compassion, and strength to the myeloproliferative neoplasm (MPN) community.

CRANBURY, N.J.–(BUSINESS WIRE)–#DevonStill–CURE Media Group, the industry-leading multimedia platform devoted to cancer updates and research that reaches more than one million patients, has named the winners of the MPN Heroes® Recognition Program. The virtual celebration will take place tonight from 6 to 7:30 p.m. CST.

Keynote speaker Devon Still, former professional athlete, entrepreneur, motivational speaker, author and advocate for childhood cancer awareness, will join in this year’s annual evening of gratitude and celebration honoring these eight remarkable heroes who have gone above and beyond, making a difference in the field of rare blood cancers known as myeloproliferative neoplasms (MPNs).

The following individuals will be recognized in the Commitment to the Individual category:

The second category honors MPN specialists whose efforts have helped the broader MPN community:

“These incredible heroes have truly dedicated themselves to improving the lives of people with myeloproliferative neoplasms,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, parent company of CURE Media Group. “This year marks the eighth anniversary of the MPN Heroes® Recognition Program, and we look forward to an amazing celebration this evening recognizing these champions who have made a difference in MPN care.”

The MPN Heroes® Recognition Program is sponsored by Incyte and CURE Media Group, publishers of CURE® magazine. Incyte partners with CURE Media Group to support the program, with CURE® hosting the annual MPN Heroes Celebration Event. The honorees were nominated by colleagues, patients and caregivers for their heroic contributions and dedication. The selected MPN Heroes were chosen by an independent judging panel comprised of patient advocates and healthcare professionals. Individuals or entities supported through funding or directed by Incyte were not eligible for consideration or recognition. Supporting the MPN community is an ongoing priority for Incyte, a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development, and commercialization of proprietary therapeutics.

About CURE Media Group

CURE Media Group is the leading resource for cancer updates, research, and education. It features a full suite of media products, including the industry-leading website CUREtoday.com; innovative video programs such as “CURE Connections®”; a series of widely attended live events; CURE® magazine, which reaches more than 1 million readers; and the dynamic website for oncology nurses, OncNursingNews.com, and its companion publication, Oncology Nursing News®. CURE Media Group is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

MPN Heroes® is a registered trademark of Incyte. Other trademarks are the property of their respective owners.

Contacts

CURE Media Group Media Contact
Alexandra Ventura, 609-716-7777

aventura@mjhlifesciences.com

Exit mobile version